Inventor · disambiguated record
Zheming Ruan
Also filed as: RUAN ZHEMING
13 granted patents·7 pending applications·59 citations·filing 2004–2024
86Inventor score
Top patents by PatentIndex Score
20 records- 0194US7579360B2Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2006·Granted Aug 25, 2009·37 cites·49 claims
- 0283US7459460B2Trisubstituted heteroaromatic compounds as calcium sensing receptor modulatorsBRISTOL MYERS SQUIBB CO·Filed 2004·Granted Dec 2, 2008·16 cites·16 claims
- 0381US10947263B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Mar 16, 2021·2 cites·21 claims
- 0477US12331045B2Substituted phenyl oxazolone compoundsBRISTOL MYERS SQUIBB CO·Filed 2024·Granted Jun 17, 2025·0 cites·27 claims
- 0577US11660311B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted May 30, 2023·2 cites·17 claims
- 0675US10023576B2Heteroaryl substituted pyrrolotriazine amine compounds as PI3K inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Jul 17, 2018·2 cites·10 claims
- 0765US2025145665A1Macrocyclic peptides useful as modulators of tnf alphaBRISTOL MYERS SQUIBB CO·Filed 2024·Application pending·0 cites
- 0861US11339185B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted May 24, 2022·0 cites·11 claims
- 0958US10519187B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Dec 31, 2019·0 cites·70 claims
- 1058US2024217982A1Kras inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1158US2024317769A1Kras g12d inhibitorsBRISTOL MYERS SQUIBB CO·Filed 2022·Application pending·0 cites
- 1257US8148396B2Triazolopyridine 11-beta hydroxysteroid dehydrogenase type I inhibitorsLI JAMES J·Filed 2009·Granted Apr 3, 2012·0 cites·18 claims
- 1352US11945834B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2019·Granted Apr 2, 2024·0 cites·16 claims
- 1449US12473290B2Imidazopyridazine compounds useful as modulators of IL-12, IL-23 and/or IFN alpha responsesBRISTOL MYERS SQUIBB CO·Filed 2020·Granted Nov 18, 2025·0 cites·3 claims
- 1549US2022306630A1AGONISTS OF ROR GAMMAtBRISTOL MYERS SQUIBB CO·Filed 2020·Application pending·0 cites
- 1647US2006235028A1Inhibitors of 11-beta hydroxysteroid dehydrogenase type ILI JAMES J·Filed 2006·Application pending·0 cites
- 1745US2007238669A1Human glucagon-like-peptide-1 modulators and their use in the treatment of diabetes related conditionsBRISTOL MYERS SQUIBB CO·Filed 2007·Application pending·0 cites
- 1844US10744150B2Cyclic dinucleotides as anticancer agentsBRISTOL MYERS SQUIBB CO·Filed 2018·Granted Aug 18, 2020·0 cites·54 claims
- 1944US2011077395A1Inhibitors of 11-beta hydroxysteroid dehydrogenase type iBRISTOL MYERS SQUIBB CO·Filed 2010·Application pending·0 cites
- 2035US10214537B2Bicyclic heteroaryl amine compoundsBRISTOL MYERS SQUIBB CO·Filed 2015·Granted Feb 26, 2019·0 cites·9 claims
Join the waitlist — get patent alerts
Get an alert when Zheming Ruan files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →